Reactive oxygen species mediated sustained activation of protein kinase C alpha and extracellular signal-regulated kinase for migration of human hepatoma cell Hepg2 - PubMed (original) (raw)
Reactive oxygen species mediated sustained activation of protein kinase C alpha and extracellular signal-regulated kinase for migration of human hepatoma cell Hepg2
Wen-Sheng Wu et al. Mol Cancer Res. 2006 Oct.
Abstract
The tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) can trigger growth inhibition, epithelial-mesenchymal transition (EMT)-like cell scattering, and migration of hepatoma cells HepG2 in a protein kinase C-alpha (PKC-alpha)-dependent manner. Saikosaponin a, an ingredient of antitumorigenic Chinese herb Sho-Saiko-to, inhibited cell growth but did not induce EMT-like cell scattering and cell migration of HepG2. Saikosaponin a and TPA induced transient (for 30 minutes) and sustained (until 6 hours) phosphorylation of extracellular signal-regulated kinase (ERK), respectively. Generation of the reactive oxygen species (ROS) was induced by TPA, but not saikosaponin a, for 3 hours. As expected, scavengers of ROS, such as superoxide dismutase, catalase, and mannitol, and the thiol-containing antioxidant N-acetylcystein dramatically suppressed the TPA-triggered cell migration but not growth inhibition of HepG2. The generation of ROS induced by TPA was PKC, but not ERK, dependent. On the other hand, scavengers of ROS and N-acetylcystein also prevented PKC activation and ERK phosphorylation induced by TPA. On the transcriptional level, TPA can induce gene expression of integrins alpha5, alpha6, and beta1 and reduce gene expression of E-cahedrin in a PKC- and ROS-dependent manner. In conclusion, ROS play a central role in mediating TPA-triggered sustained PKC and ERK signaling for regulation of gene expression of integrins and E-cahedrin that are responsible for EMT and migration of HepG2.
Similar articles
- Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
Wen-Sheng W. Wen-Sheng W. Cancer Lett. 2006 Jul 28;239(1):27-35. doi: 10.1016/j.canlet.2005.07.034. Epub 2005 Sep 19. Cancer Lett. 2006. PMID: 16169661 - Reactive oxygen species-mediated PKC and integrin signaling promotes tumor progression of human hepatoma HepG2.
Hu CT, Wu JR, Cheng CC, Wang S, Wang HT, Lee MC, Wang LJ, Pan SM, Chang TY, Wu WS. Hu CT, et al. Clin Exp Metastasis. 2011 Dec;28(8):851-63. doi: 10.1007/s10585-011-9416-6. Epub 2011 Aug 14. Clin Exp Metastasis. 2011. PMID: 21842414 - Activation of protein kinase C alpha is required for TPA-triggered ERK (MAPK) signaling and growth inhibition of human hepatoma cell HepG2.
Wen-Sheng W, Jun-Ming H. Wen-Sheng W, et al. J Biomed Sci. 2005;12(2):289-96. doi: 10.1007/s11373-005-1210-5. J Biomed Sci. 2005. PMID: 15917995 - The signaling mechanism of ROS in tumor progression.
Wu WS. Wu WS. Cancer Metastasis Rev. 2006 Dec;25(4):695-705. doi: 10.1007/s10555-006-9037-8. Cancer Metastasis Rev. 2006. PMID: 17160708 Review. - Protein kinase C-α and the regulation of diverse cell responses.
Singh RK, Kumar S, Gautam PK, Tomar MS, Verma PK, Singh SP, Kumar S, Acharya A. Singh RK, et al. Biomol Concepts. 2017 Sep 26;8(3-4):143-153. doi: 10.1515/bmc-2017-0005. Biomol Concepts. 2017. PMID: 28841566 Review.
Cited by
- Role of NOX1 and NOX5 in protein kinase C/reactive oxygen species‑mediated MMP‑9 activation and invasion in MCF‑7 breast cancer cells.
Song HK, Kim JM, Noh EM, Youn HJ, Lee YR. Song HK, et al. Mol Med Rep. 2024 Oct;30(4):188. doi: 10.3892/mmr.2024.13312. Epub 2024 Sep 2. Mol Med Rep. 2024. PMID: 39219290 Free PMC article. - ERK1/2-SOX9/FOXL2 axis regulates ovarian steroidogenesis and favors the follicular-luteal transition.
Baddela VS, Michaelis M, Tao X, Koczan D, Vanselow J. Baddela VS, et al. Life Sci Alliance. 2023 Aug 2;6(10):e202302100. doi: 10.26508/lsa.202302100. Print 2023 Oct. Life Sci Alliance. 2023. PMID: 37532283 Free PMC article. - Nfe2l2 Regulates Metabolic Rewiring and Epigenetic Reprogramming in Mediating Cancer Protective Effect by Fucoxanthin.
Wang L, Wu R, Sargsyan D, Su S, Kuo HC, Li S, Chou P, Sarwar MS, Phadnis A, Wang Y, Su X, Kong AN. Wang L, et al. AAPS J. 2022 Jan 18;24(1):30. doi: 10.1208/s12248-022-00679-0. AAPS J. 2022. PMID: 35043283 - Playing the Devil's Advocate: Should We Give a Second Chance to mTOR Inhibition in Renal Clear Cell Carcinoma? - ie Strategies to Revert Resistance to mTOR Inhibitors.
Pezzicoli G, Filoni E, Gernone A, Cosmai L, Rizzo M, Porta C. Pezzicoli G, et al. Cancer Manag Res. 2021 Oct 4;13:7623-7636. doi: 10.2147/CMAR.S267220. eCollection 2021. Cancer Manag Res. 2021. PMID: 34675658 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous